159 related articles for article (PubMed ID: 14516818)
1. Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema.
Scott IU; Flynn HW; Rosenfeld PJ
Am J Ophthalmol; 2003 Oct; 136(4):737-9. PubMed ID: 14516818
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
Saraiva VS; Sallum JM; Farah ME
Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Park CH; Jaffe GJ; Fekrat S
Am J Ophthalmol; 2003 Sep; 136(3):419-25. PubMed ID: 12967793
[TBL] [Abstract][Full Text] [Related]
5. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone for refractory pseudophakic macular edema.
Benhamou N; Massin P; Haouchine B; Audren F; Tadayoni R; Gaudric A
Am J Ophthalmol; 2003 Feb; 135(2):246-9. PubMed ID: 12566041
[TBL] [Abstract][Full Text] [Related]
7. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone.
Larsson J; Zhu M; Sutter F; Gillies MC
Am J Ophthalmol; 2005 May; 139(5):802-6. PubMed ID: 15860283
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Ozdemir H; Karacorlu M; Karacorlu S
Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema.
Jonas JB; Kreissig I; Degenring RF
Am J Ophthalmol; 2003 Aug; 136(2):384-6. PubMed ID: 12888077
[TBL] [Abstract][Full Text] [Related]
13. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Ozdemir H; Karacorlu M; Karacorlu SA
Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
[TBL] [Abstract][Full Text] [Related]
14. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Bakri SJ; Larson TA
Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
16. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
Batioğlu F; Ozmert E; Parmak N; Celik S
Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.
Hogewind BF; Zijlstra C; Klevering BJ; Hoyng CB
Eur J Ophthalmol; 2008; 18(3):429-34. PubMed ID: 18465727
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
Jonas JB; Kreissig I; Degenring RF
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
